Translation research for chronic disease: The case of diabetes

Diabetes Care

Volumn 23, Issue 12, 2000, Pages 1794-1798

  Narayan, K M Venkat ^a,b   Gregg, Edward W ^a   Engelgau, Michael M ^a   Moore, Bernice ^a   Thompson, Theodore J ^a   Williamson, David F ^a   Vinicor, Frank ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b Mailstop K 68 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL RESEARCH; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DRUG EFFICACY; EARLY DIAGNOSIS; HEALTH PROGRAM; HUMAN; MORBIDITY; OBSERVATION; PUBLIC HEALTH; VACCINATION;

EID: 0033653222     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.12.1794     Document Type: Article

References (43)

1. Closing the gap: The problem of diabetes mellitus in the United States
2. Is diabetes a public-health disorder?
3. The uses of outcomes research for medical effectiveness, quality of care, and reimbursement in type 2 diabetes
4. Economic consequences of diabetes mellitus in the U.S. in 1997
5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
6. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
7. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38)
8. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension: Systolic Hypertension in the Elderly Program Cooperative Research Group
9. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: A subgroup analysis of the Scandinavian Simvaslatin Survival Study (4S)
10. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: Subgroup analyses in the cholesterol and recurrent events (CARE) Trial: The Care Investigators
11. Aspirin effects on mortality and morbidity m patients with diabetes mellitus: Early Treatment Diabetic Retinopathy Study Report 14
12. Collaborative overview of randomized trials of antiplatelet therapy I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
13. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus: A 7-year follow-up study
14. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE study
15. Early photocoagulation for diabetic retinopathy: ETDRS report number 9
16. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus: A randomized controlled trial
17. Evaluation of a diabetic foot screening and protection programme
18. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens
19. Lifetime benefits and costs of intensive therapy as practices in the Diabetes Control and Complications Trial
20. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40
21. Cost effectiveness of LDL-C reduction in diabetic CHD patients: Implications from the Scandinavian Simvastatin Survival Study (4S)
22. Preventive eye care in people with diabetes is cost-saving to the federal government
23. Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus
24. Racial and ethnic differences in glycemic control of adults with type 2 diabetes
25. Aspirin use among Americans with diabetes! Estimates from NHANES III
26. Population-based assessment of the level of care among adults with diabetes in the U.S
27. Influenza and pneumococcal vaccination rates among persons with diabetes mellitus: United States, 1997
28. Exploring and expanding the research agenda for diabetes in managed care: A report of a Centers for Disease Control and Prevention-Managed Care Workshop
29. Influences on control in diabetes mellitus: Patient, doctor, practice, or delivery of care
30. Managing chronic disease
31. Starting insulin therapy in patients with type 2 diabetes: Effectiveness, complications, and resource utilization
32. Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization
33. Randomised controlled trial Of patient centered care of diabetes in general practice: Impact on current wellbeing and future risk: The Diabetes Care From Diagnosis Research Team
34. Treating type 2 diabetes: Study was conducted in exemplary fashion
35. The definition of quality
36. If diabetes is a public health problem, why not treat it as one? A population-based approach to chronic illness
37. Computerized decision support based on a clinical practice guideline improves compliance with care standards
38. Diabetes management in a health maintenance organization: Efficacy of care management using cluster visits
39. Evaluation of the effect of performance monitoring and feedback on care process, utilization, and outcomes
40. TRIAD: A multicenter study of managed care and diabetes quality of care, costs, and outcomes